{"id":"https://openalex.org/W3006443583","doi":"https://doi.org/10.1007/s40264-020-00913-8","title":"Sex Differences in Adverse Drug Reactions of Metformin: A Longitudinal Survey Study","display_name":"Sex Differences in Adverse Drug Reactions of Metformin: A Longitudinal Survey Study","alternate_titles":[],"publication_year":2020,"publication_date":"2020-02-11","ids":{"openalex":"https://openalex.org/W3006443583","doi":"https://doi.org/10.1007/s40264-020-00913-8","mag":"3006443583","pmid":"https://pubmed.ncbi.nlm.nih.gov/32048185","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7165141"},"language":"en","primary_location":{"id":"doi:10.1007/s40264-020-00913-8","doi":"https://doi.org/10.1007/s40264-020-00913-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40264-020-00913-8","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40264-020-00913-8.pdf","source":{"id":"https://openalex.org/S49488433","display_name":"Drug Safety","issn_l":"0114-5916","issn":["0114-5916","1179-1942"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Safety","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3006443583"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s40264-020-00913-8.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012566217","display_name":"Sieta T. de Vries","orcid":"https://orcid.org/0000-0001-6090-2434","observed_orcids":["https://orcid.org/0000-0001-6090-2434"]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]},{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sieta T. de Vries","raw_affiliation_strings":["Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"],"raw_orcid":"https://orcid.org/0000-0001-6090-2434","affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands","institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029966007","display_name":"Petra Denig","orcid":"https://orcid.org/0000-0002-7929-4739","observed_orcids":["https://orcid.org/0000-0002-7929-4739"]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]},{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Petra Denig","raw_affiliation_strings":["Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"],"raw_orcid":"https://orcid.org/0000-0002-7929-4739","affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands","institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059895069","display_name":"Corine Ekhart","orcid":"https://orcid.org/0000-0002-2252-0467","observed_orcids":["https://orcid.org/0000-0002-2252-0467"]},"institutions":[{"id":"https://openalex.org/I4210139651","display_name":"Netherlands Pharmacovigilance Centre Lareb","ror":"https://ror.org/04fp8ns78","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210139651"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Corine Ekhart","raw_affiliation_strings":["Netherlands Pharmacovigilance Center Lareb, 's-Hertogenbosch, The Netherlands"],"raw_orcid":"https://orcid.org/0000-0002-2252-0467","affiliations":[{"raw_affiliation_string":"Netherlands Pharmacovigilance Center Lareb, 's-Hertogenbosch, The Netherlands","institution_ids":["https://openalex.org/I4210139651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004765738","display_name":"Peter G. M. Mol","orcid":"https://orcid.org/0000-0002-4262-3180","observed_orcids":["https://orcid.org/0000-0002-4262-3180"]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]},{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]},{"id":"https://openalex.org/I4210150351","display_name":"Medicines Evaluation Board","ror":"https://ror.org/05mv4rb84","country_code":"NL","type":"education","lineage":["https://openalex.org/I4210150351"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter G. M. Mol","raw_affiliation_strings":["Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands","Dutch Medicines Evaluation Board, Utrecht, The Netherlands"],"raw_orcid":"https://orcid.org/0000-0002-4262-3180","affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands","institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384"]},{"raw_affiliation_string":"Dutch Medicines Evaluation Board, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I4210150351"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073876435","display_name":"Eug\u00e8ne van Puijenbroek","orcid":"https://orcid.org/0000-0002-2236-1398","observed_orcids":["https://orcid.org/0000-0002-2236-1398"]},"institutions":[{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]},{"id":"https://openalex.org/I4210139651","display_name":"Netherlands Pharmacovigilance Centre Lareb","ror":"https://ror.org/04fp8ns78","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210139651"]}],"countries":["NL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Eugene P. van Puijenbroek","raw_affiliation_strings":["Groningen Research Institute of Pharmacy, Pharmacotherapy, -Epidemiology, & -Economics, University of Groningen, Groningen, The Netherlands. e.vanpuijenbroek@lareb.nl","Netherlands Pharmacovigilance Center Lareb, 's-Hertogenbosch, The Netherlands. e.vanpuijenbroek@lareb.nl","Netherlands Pharmacovigilance Center Lareb, 's-Hertogenbosch, The Netherlands"],"raw_orcid":"https://orcid.org/0000-0002-2236-1398","affiliations":[{"raw_affiliation_string":"Groningen Research Institute of Pharmacy, Pharmacotherapy, -Epidemiology, & -Economics, University of Groningen, Groningen, The Netherlands. e.vanpuijenbroek@lareb.nl","institution_ids":["https://openalex.org/I169381384"]},{"raw_affiliation_string":"Netherlands Pharmacovigilance Center Lareb, 's-Hertogenbosch, The Netherlands. e.vanpuijenbroek@lareb.nl","institution_ids":["https://openalex.org/I4210139651"]},{"raw_affiliation_string":"Netherlands Pharmacovigilance Center Lareb, 's-Hertogenbosch, The Netherlands","institution_ids":["https://openalex.org/I4210139651"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5073876435"],"corresponding_institution_ids":["https://openalex.org/I169381384","https://openalex.org/I4210139651"],"apc_list":{"value":3860,"currency":"USD","value_usd":3860},"apc_paid":{"value":3860,"currency":"USD","value_usd":3860},"fwci":5.4668,"has_fulltext":true,"cited_by_count":76,"citation_normalized_percentile":{"value":0.96887912,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":94,"max":100},"biblio":{"volume":"43","issue":"5","first_page":"489","last_page":"495"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13252","display_name":"Sex and Gender in Healthcare","score":0.7192000150680542,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13252","display_name":"Sex and Gender in Healthcare","score":0.7192000150680542,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.22509999573230743,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.016499999910593033,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":1.0},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.9879999756813049},{"id":"https://openalex.org/keywords/sex-differences","display_name":"sex differences","score":1.0},{"id":"https://openalex.org/keywords/women","display_name":"women","score":0.8090000152587891},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.550000011920929},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.9229999780654907},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.7990000247955322},{"id":"https://openalex.org/keywords/self-reported-adverse-events","display_name":"self-reported adverse events","score":0.5320000052452087},{"id":"https://openalex.org/keywords/prescribed-dose","display_name":"prescribed dose","score":0.30399999022483826}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.960820734500885},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.8789994716644287},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.6197119951248169},{"id":"https://openalex.org/C127808970","wikidata":"https://www.wikidata.org/wiki/Q385989","display_name":"Bonferroni correction","level":2,"score":0.5693724155426025},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5430755615234375},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5081310272216797},{"id":"https://openalex.org/C2993432071","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Drug reaction","level":3,"score":0.4294966757297516},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.42402344942092896},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.18767863512039185},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.0},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008137","descriptor_name":"Longitudinal Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009426","descriptor_name":"Netherlands","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012737","descriptor_name":"Sex Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016907","descriptor_name":"Adverse Drug Reaction Reporting Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D060735","descriptor_name":"Pharmacovigilance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.1007/s40264-020-00913-8","doi":"https://doi.org/10.1007/s40264-020-00913-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40264-020-00913-8","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40264-020-00913-8.pdf","source":{"id":"https://openalex.org/S49488433","display_name":"Drug Safety","issn_l":"0114-5916","issn":["0114-5916","1179-1942"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Safety","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7165141","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7165141/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Saf","raw_type":"Text"},{"id":"pmid:32048185","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32048185","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug safety","raw_type":"Journal Article"},{"id":"pmh:oai:pure.rug.nl:openaire/0998eb10-dc52-40f8-afa7-fb1a40d42cd9","doi":null,"is_oa":true,"landing_page_url":"https://research.rug.nl/en/publications/0998eb10-dc52-40f8-afa7-fb1a40d42cd9","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"de Vries, S T, Denig, P, Ekhart, C, Mol, P G M & van Puijenbroek, E P 2020, 'Sex Differences in Adverse Drug Reactions of Metformin : A Longitudinal Survey Study', Drug Safety, vol. 43, no. 5, pp. 489\u2013495. https://doi.org/10.1007/s40264-020-00913-8","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:RePEc:spr:drugsa:v:43:y:2020:i:5:d:10.1007_s40264-020-00913-8","doi":null,"is_oa":false,"landing_page_url":"http://link.springer.com/10.1007/s40264-020-00913-8","pdf_url":null,"source":{"id":"https://openalex.org/S4306401271","display_name":"RePEc: Research Papers in Economics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I77793887","host_organization_name":"Federal Reserve Bank of St. Louis","host_organization_lineage":["https://openalex.org/I77793887"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/0998eb10-dc52-40f8-afa7-fb1a40d42cd9","doi":null,"is_oa":true,"landing_page_url":"https://research.rug.nl/en/publications/0998eb10-dc52-40f8-afa7-fb1a40d42cd9","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Drug Safety, 43(5). ADIS INT LTD","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1007/s40264-020-00913-8","doi":"https://doi.org/10.1007/s40264-020-00913-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40264-020-00913-8","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40264-020-00913-8.pdf","source":{"id":"https://openalex.org/S49488433","display_name":"Drug Safety","issn_l":"0114-5916","issn":["0114-5916","1179-1942"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Safety","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[{"id":"https://openalex.org/G434337789","display_name":null,"funder_award_id":"HORIZON2020","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"},{"id":"https://openalex.org/G4387166743","display_name":null,"funder_award_id":"849100006","funder_id":"https://openalex.org/F4320321007","funder_display_name":"ZonMw"},{"id":"https://openalex.org/G6541479890","display_name":"Personalised Medicine in Diabetic Chronic Disease Management","funder_award_id":"754425","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"}],"funders":[{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320321007","display_name":"ZonMw","ror":"https://ror.org/01yaj9a77"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3006443583.pdf","grobid_xml":"https://content.openalex.org/works/W3006443583.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W2002537054","https://openalex.org/W2022817684","https://openalex.org/W2023984564","https://openalex.org/W2036051294","https://openalex.org/W2037617410","https://openalex.org/W2056347227","https://openalex.org/W2085752173","https://openalex.org/W2104353818","https://openalex.org/W2106237303","https://openalex.org/W2110541324","https://openalex.org/W2129240221","https://openalex.org/W2139432419","https://openalex.org/W2159611971","https://openalex.org/W2160088494","https://openalex.org/W2268421734","https://openalex.org/W2345328813","https://openalex.org/W2440597712","https://openalex.org/W2567000504","https://openalex.org/W2568798765","https://openalex.org/W2735771284","https://openalex.org/W2742954355","https://openalex.org/W2935014396","https://openalex.org/W2952024366","https://openalex.org/W4212810717","https://openalex.org/W4236074123","https://openalex.org/W4245367233"],"related_works":["https://openalex.org/W2268421734","https://openalex.org/W2935014396","https://openalex.org/W2617757413","https://openalex.org/W2090909991","https://openalex.org/W4283695675","https://openalex.org/W2791944981","https://openalex.org/W2909948739","https://openalex.org/W2356513026","https://openalex.org/W2129122186","https://openalex.org/W2981369305"],"abstract_inverted_index":{"INTRODUCTION:":[0],"In":[1,230],"general,":[2,231],"women":[3,232],"more":[4,199],"often":[5,200],"experience":[6],"metformin-associated":[7,63],"adverse":[8],"drug":[9],"reactions":[10],"(ADRs)":[11],"than":[12,201,241],"men.":[13],"OBJECTIVES:":[14],"We":[15],"aimed":[16],"to":[17,35,104,235],"assess":[18],"whether":[19],"sex":[20,40,60],"differences":[21,41,61,146,256,272],"in":[22,42,54,62,72,147,153,257,262,273,283],"reported":[23,196,234,258],"ADRs":[24,64,71,151,259],"for":[25,173],"metformin":[26,46,87,143,267,292],"are":[27],"observed":[28,278],"at":[29,114,120,158,207,210,247,294],"different":[30],"times":[31,110],"after":[32,111,228,266,279],"initiation,":[33,268],"and":[34,65,119,124,139,152,165,219],"explore":[36],"their":[37,97],"concurrence":[38],"with":[39],"the":[43,56,90,131,140,148,154,208,248,263],"dose":[44,141,155,240],"of":[45,59,70,133,142,150,188],"over":[47],"time.":[48],"This":[49,76],"may":[50,66],"guide":[51,67],"future":[52],"studies":[53],"assessing":[55],"involved":[57],"mechanisms":[58],"sex-specific":[68],"management":[69],"clinical":[73],"practice.":[74],"METHODS:":[75],"study":[77],"has":[78],"a":[79,106,176,238],"longitudinal":[80],"design":[81],"using":[82,161],"data":[83],"about":[84],"patients":[85,134,190],"initiating":[86],"collected":[88],"by":[89],"Dutch":[91],"National":[92],"Pharmacovigilance":[93],"Center":[94],"Lareb":[95],"through":[96],"Intensive":[98],"Monitoring":[99],"program.":[100],"Patients":[101],"were":[102,130,156,233,260,277],"asked":[103],"complete":[105],"web-based":[107],"questionnaire":[108],"six":[109],"initiation":[112],"(i.e.,":[113],"2":[115,211],"weeks,":[116],"6":[117,220],"weeks":[118,212,221,265],"3,":[121],"6,":[122],"9,":[123],"12":[125],"months).":[126],"The":[127,186],"outcome":[128],"variables":[129],"proportion":[132],"reporting":[135],"any":[136],"ADR":[137,198],"(primary)":[138],"(secondary).":[144],"Sex":[145,255],"proportions":[149],"tested":[157],"each":[159],"assessment":[160,209,250],"Pearson":[162],"Chi-Squared":[163],"tests":[164],"Wilcoxon":[166],"rank-sum":[167],"tests,":[168],"respectively.":[169],"Using":[170],"Bonferroni":[171],"adjustment":[172],"multiple":[174],"testing,":[175],"p":[177,216,225],"value":[178],"<":[179,217,252],"0.01":[180],"was":[181,191,204],"considered":[182],"statistically":[183,205,245,270],"significant.":[184],"RESULTS:":[185],"number":[187],"included":[189],"1712":[192],"(40.9%":[193],"women).":[194],"Women":[195],"an":[197],"men,":[202,242],"which":[203,243],"significant":[206,246,271],"(34%":[213],"vs":[214,223],"25%,":[215],"0.001),":[218],"(37%":[222],"28%,":[224],"=":[226],"0.001)":[227],"initiation.":[229,296],"be":[236],"prescribed":[237,275,290],"lower":[239,291],"became":[244],"9-month":[249],"(p":[251],"0.01).":[253],"CONCLUSIONS:":[254],"seen":[261],"first":[264],"whereas":[269],"self-reported":[274],"dosing":[276],"several":[280],"months.":[281],"Patients,":[282],"particular":[284],"women,":[285],"might":[286],"benefit":[287],"from":[288],"being":[289],"doses":[293],"treatment":[295]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3006443583","counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":14},{"year":2024,"cited_by_count":19},{"year":2023,"cited_by_count":14},{"year":2022,"cited_by_count":14},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2020-02-24T00:00:00"}
